-
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study
D'Haens, G. R., löwenberg, M., Baert, F., Bossuyt, P., Molnár, T., Hoentjen, F., Clasquin, E., Gecse, K. B., Hulshoff, M. S., de Hertogh, G., Lenfant, M., Oldenburg, L. & Vermeire, S. V., 1 Jan 2026, In: lancet. Gastroenterology & hepatology. 11, 1, p. 12-21Research output: Contribution to journal › Article › Academic › peer-review
-
Pregnancy with a Stoma is Feasible, though Associated with Manageable Complications
Bouwknegt, D. G., van der Weide, A. H. C., Dijkstra, G., Goetgebuer, R. L., Oldenburg, L., van Dop, W. A., Hirdes, M. M. C., Prins, J. R. & Dutch Initiative on Crohn and Colitis (ICC), 1 Aug 2025, In: Inflammatory Bowel Diseases. 31, 8, p. 2195-2203 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
D'Haens, G., Taxonera, C., Lopez-Sanroman, A., Nos, P., Danese, S., Armuzzi, A., Roblin, X., Peyrin-Biroulet, L., West, R., Mares, W. G. N., Duijvestein, M., Gecse, K. B., Feagan, B. G., Zou, G., Hulshoff, M. S., Mookhoek, A., Oldenburg, L., Clasquin, E., Bouhnik, Y. & Laharie, D., 1 Jan 2025, In: The Lancet Gastroenterology and Hepatology. 10, 1, p. 26-33 8 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
